Literature DB >> 9151166

Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study.

X F Guan1, W L Qiu, R G He, X J Zhou.   

Abstract

Lung metastasis is very common in patients with adenoid cystic carcinoma (ACC). The purpose of the present study is to establish a model for an experimental study of ACC metastatic mechanisms and antimetastatic procedures. After five repeated selection in vivo, combined with an in vitro cloning technique and analysis of platelet aggregation activity, a clone (Acc-M) highly metastatic to the lung was selected from an ACC cell line (Acc-2). The metastatic rate was 96% vs 18% for Acc-M and the Acc-2 cell line. The metastatic rate and the weight of the lung with metastases correlated positively with platelet aggregation activity. The present study might be important for research into mechanisms of ACC metastases.

Entities:  

Mesh:

Year:  1997        PMID: 9151166     DOI: 10.1016/s0901-5027(05)80830-6

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  12 in total

1.  Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.

Authors:  Ryuichi Murase; Tomoki Sumida; Rumi Kawamura; Akiko Onishi-Ishikawa; Hiroyuki Hamakawa; Sean D McAllister; Pierre-Yves Desprez
Journal:  Cancer Lett       Date:  2016-04-14       Impact factor: 8.679

2.  Protein and mRNA characterization in high and low metastasis adenoid cystic carcinoma cell lines.

Authors:  Jie-lin Yang; Nai-shuo Zhu; Ying Wang; Xiao-feng Guan; Zhao-xin Zheng
Journal:  Mol Biol Rep       Date:  2004-12       Impact factor: 2.316

3.  Expression and function of CXCR4 in human salivary gland cancers.

Authors:  Daisuke Uchida; Nobuyuki Kuribayashi; Makoto Kinouchi; Go Ohe; Tetsuya Tamatani; Hirokazu Nagai; Youji Miyamoto
Journal:  Clin Exp Metastasis       Date:  2012-07-31       Impact factor: 5.150

4.  NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro.

Authors:  Jiali Zhang; Bin Peng
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

5.  Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.

Authors:  Jun Jia; Wei Zhang; Jian-Ying Liu; Gang Chen; Hui Liu; Hao-Yan Zhong; Bing Liu; Yu Cai; Jia-Li Zhang; Yi-Fang Zhao
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

6.  Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.

Authors:  Daisuke Uchida; Tomitaro Onoue; Nasima-Mila Begum; Nobuyuki Kuribayashi; Yoshifumi Tomizuka; Tetsuya Tamatani; Hirokazu Nagai; Youji Miyamoto
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

7.  Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.

Authors:  Tomoki Sumida; Ryuichi Murase; Akiko Onishi-Ishikawa; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  BMC Cancer       Date:  2013-03-22       Impact factor: 4.430

8.  In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma.

Authors:  Jiali Zhang; Bin Peng
Journal:  BMC Cancer       Date:  2007-06-01       Impact factor: 4.430

9.  Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2.

Authors:  Janyaporn Phuchareon; Yoshihito Ohta; Jonathan M Woo; David W Eisele; Osamu Tetsu
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

10.  Different cDNA microarray patterns of gene expression reflecting changes during metastatic progression in adenoid cystic carcinoma.

Authors:  Dan Huang; Wantao Chen; Ronggen He; Fan Yu; Zhiyuan Zhang; Weiliu Qiu
Journal:  World J Surg Oncol       Date:  2003-12-19       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.